Loading…

Resmed entered a definitive merger agreement to acquire Noctrix Health for $340 million. Noctrix developed the Nidra Tonic Motor Activation System, a non-invasive wearable therapy for Restless Legs Syndrome. The acquisition is expected to close on or around June 1, 2026.
“RLS treatments from Noctrix are non-invasive, clinically proven and drug-free, just like our CPAP, APAP and bi-level therapies.”massdevice.com
Summarized from public sources; check the original articles before acting on it.